Real Medical Services Expenditures by Disease: Diseases of the Genitourinary System, Blended Account Basis (DIGESYREXBLEND) | FRED | St. Louis Fed
- Rows
- 22
- Columns
- 2
- Data range
- 2000-01-01 to 2021-01-01
Graph and download economic data for Real Medical Services Expenditures by Disease: Diseases of the Genitourinary System, Blended Account Basis (DIGESYREXBLEND) from 2000 to 2021 about genitourinary, disease, healthcare, medical, health, expenditures, services, real, and USA.
AI analysis
Data Analysis: Real Medical Services Expenditures — Genitourinary System Diseases (DIGESYREXBLEND)
1. Dataset Overview and Value
This dataset, sourced from the Federal Reserve Bank of St. Louis (FRED) via their public API (fred.stlouisfed.org/graph/fredgraph.csv), tracks real (inflation-adjusted) medical services expenditures for genitourinary system diseases on a "blended account basis" from 2000 to 2021. FRED is a highly reputable, actively maintained economic data repository, which lends strong credibility to this series. The blended account methodology suggests this data aggregates spending across multiple payer types (Medicare, Medicaid, private insurance, out-of-pocket), making it valuable for macro-level healthcare economics research. Its annual frequency and 21-year span make it well-suited for long-run trend analysis and correlation with other health expenditure or economic indicators, though the dataset was last structured with data through 2021, so freshness for very recent policy analysis is limited.
2. Data Quality Observations
The dataset is clean by conventional metrics: zero null cells across both columns and 22 distinct values in each column matching the 22 total rows — indicating no missing observations and no apparent duplicate collapsing issues at the value level. The observationdate column also shows 22 distinct dates, consistent with one observation per year, which is a good sign of structural integrity (no duplicate timestamps). The duplicate-row and type-mismatch fields are marked as pending Phase D recomputation, so a final duplicate-count verification is still outstanding — this should be confirmed before treating the dataset as fully validated. No sample rows were available for visual inspection, which limits deeper anomaly-checking (e.g., verifying value formatting or unexpected outliers), so I'd flag that as a follow-up step.
3. Key Column Distributions
The core metric, DIGESYREXBLEND, ranges from 81.22 to 120.99 (a ~49% spread from min to max), with a mean of 101.11 and median of 105.315 — the mean being notably lower than the median indicates a left-skewed distribution, corroborated by the skewness coefficient of -0.352. This suggests expenditures were compressed toward higher values in more years, with a longer tail toward lower values (likely earlier years, given expenditures typically trend upward over time before inflation-adjustment or methodology shifts). The interquartile range (Q1=87.29, Q3=108.78) spans about 21.5 points, with a standard deviation of 12.79 relative to the mean — a coefficient of variation around 12.6%, indicating moderate but not extreme volatility over the two-decade window. With only 22 observations, formal outlier detection is constrained, but the gap between the median and Q3 (105.32 to 108.78) versus Q1 to median (87.29 to 105.32) reinforces the left-skew pattern.
4. Recommended Join Keys
The observationdate column (Date type, 0 nulls, 22 distinct values, annual granularity) is the clear and only viable join key. For cross-dataset correlation, this should be matched against other annual time series using observationdate (or a derived year field) as the key. Analysts should ensure date alignment conventions (e.g., January 1 as year-start placeholder, as seen here) match across datasets to avoid off-by-one-year join errors.
5. Complementary Datasets for Correlation Analysis
Given the health-expenditure focus, strong pairing candidates include: (a) other FRED "Real Medical Services Expenditures by Disease" series (e.g., circulatory, respiratory, musculoskeletal, mental health) to compare relative disease-category spending trends; (b) broader healthcare price indices (CPI Medical Care, PCE Healthcare deflators) to contextualize whether genitourinary spending growth outpaces general medical inflation; (c) demographic/epidemiological data on kidney disease, UTIs, or dialysis prevalence (e.g., CDC or CMS data) to explore whether expenditure trends track disease incidence; and (d) macroeconomic indicators (GDP, insurance coverage rates, Medicare/Medicaid enrollment) to assess whether spending patterns correlate with economic cycles or policy changes (e.g., ACA implementation around 2010-2014, which falls within this dataset's range).
Columns
- observation_date (date)
- DIGESYREXBLEND (decimal)